Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Short Interest Update

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) saw a large drop in short interest in February. As of February 28th, there was short interest totalling 30,200 shares, a drop of 25.6% from the February 13th total of 40,600 shares. Based on an average daily trading volume, of 765,800 shares, the short-interest ratio is presently 0.0 days.

Ono Pharmaceutical Price Performance

Shares of OTCMKTS OPHLY opened at $3.68 on Tuesday. Ono Pharmaceutical has a 1-year low of $3.21 and a 1-year high of $5.67. The stock’s 50-day moving average is $3.46 and its 200 day moving average is $3.87.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.